The increasing prevalence of obesity and its comorbidities reflects the interaction of genes that favor the storage of excess energy as fat with an environment that provides ad libitum availability of energy-dense foods and encourages an increasingly sedentary lifestyle. Although weight reduction is difficult in and of itself, anyone who has ever lost weight will confirm that it is much harder to keep the weight off once it has been lost. The over 80% recidivism rate to preweight loss levels of body fatness after otherwise successful weight loss is due to the coordinate actions of metabolic, behavioral, neuroendocrine and autonomic responses designed to maintain body energy stores (fat) at a central nervous system-defined 'ideal'. This 'adaptive thermogenesis' creates the ideal situation for weight regain and is operant in both lean and obese individuals attempting to sustain reduced body weights. Much of this opposition to sustained weight loss is mediated by the adipocyte-derived hormone 'leptin'. The multiple systems regulating energy stores and opposing the maintenance of a reduced body weight illustrate that body energy stores in general and obesity in particular are actively 'defended' by interlocking bioenergetic and neurobiological physiologies. Important inferences can be drawn for therapeutic strategies by recognizing obesity as a disease in which the human body actively opposes the 'cure' over long periods of time beyond the initial resolution of symptomatology.
Introduction
Western societies tend to regard obesity, and the inability of individuals to sustain weight loss, as largely self-imposed conditions which reflect a lack of 'will power' related to lifestyle changes. Optimal levels of adiposity are often defined by cosmetic rather than medical considerations. However, genetic, epidemiological and physiological studies indicate that body fatness/weight is regulated, and that the increasing prevalence of obesity in western societies reflects the interactions of genes favoring energy conservation and storage with an environment that enables access to food energy and a more sedentary lifestyle.
Throughout most of human evolution, the tendency to store energy as fat would likely have conferred an advantage by enabling survival during periods of prolonged energy restriction, as well as providing greater energy stores to nourish both mother and fetus during and after pregnancy. Thus, it is likely that the human genome would be enriched for alleles of genes favoring the storage of energy as adipose tissue.
1 Our current environment enables the consumption of large quantities of energy-dense foods and the maintenance of an increasingly sedentary lifestyle. Clearly not everyone has the same 'genetic risk' for obesity and, regardless of any genetic proclivities, anyone will gain weight if they consume more energy than they expend. As illustrated by diet-induced obesity-prone and -resistant mouse strains, 2 as well as humans, 3, 4 there is a heritable variability in the degree of weight gain that different individuals will experience in an adipogenic environment. This variability reflects, in part, heritable influences on how much an individual participates in such an environment by increasing energy intake and/or decreasing energy expenditure, and their metabolic responsiveness to an increase in energy intake relative to expenditure. 5 Any change in the amount of energy stored, predominantly as adipose tissue (4100 000 kcal in a 70 kg man) but also as protein and glycogen, must reflect a difference between energy taken in as food and energy expended in various forms of metabolic and physical work (see below). If energy intake and output were not regulated by interlocking control mechanisms that work concordantly to maintain energy stores, then a very small persistent change in input relative to output would, over time, lead to substantial gain or loss of stored energy. Yet, the average US adult gains only 500-1000 g of weight (B2000-2500 kcal of stored energy) per year (more pronounced in older individuals, African Americans, Native Americans and Hispanic Americans), 6 despite ingestion of B900 000-1 000 000 kcal per year. The remarkable constancy of body weight in this context, presumably without conscious constant calculation of how much energy is being consumed and/or expended by most individuals, suggests that energy intake and expenditure vary directly to maintain relatively stable energy stores.
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Metabolic responses to attempts to sustain weight loss
In long-term studies of weight-reduced children and adults, 80-90% return to their previous weight percentiles, 8 whereas studies of those successful at sustained weight loss indicate that the maintenance of a reduced degree of body fatness will probably require a lifetime of meticulous attention to energy intake and expenditure. 9, 10 The inability of most otherwise successfully weight-reduced individuals to sustain weight loss reflects the actions of potent and redundant metabolic, neuroendocrine and autonomic systems (see below). The responses of lean and obese individuals to experimental perturbations of body weight suggest that the magnitude of stored energy, particularly fat, is defended by central nervous system (CNS)-mediated mechanisms that are similar, if not identical, in lean and obese individuals. In both lean and obese individuals, there is potent 'opposition' to the maintenance of reduced body weight that is achieved by coordinated regulation of energy intake and expenditure in the CNS, mediated by signals emanating from adipose, gastrointestinal and endocrine tissues, and integrated by the liver and by CNS (see Table 1 ).
Energy expenditure
Maintenance of a X10% reduction in body weight in lean or obese individuals is accompanied by an B20-25% decline in 24-h energy expenditure. This decrease in energy for weight maintenance is 10-15% below what is predicted solely on the basis of alterations in fat and lean mass. 11, 12 Thus, a formerly obese individual will require B300-400 kcal per day less to maintain the same body weight and physical activity level as a never-obese individual of the same body weight and composition. Studies of individuals successful at sustaining weight loss indicate that reduced weight maintenance requires long-term lifestyle alterations. 9 The necessity for these long-term changes is consistent with the observation that the reduction in 24-h energy expenditure (TEE) persists in subjects who have sustained weight loss for extended periods of time (6 months-7 years) in circumstances of enforced energy restriction in the biosphere 2 project, 13 bariatric surgery 14 and lifestyle modification.
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TEE is the sum of resting energy expenditure (REE; cardiorespiratory work and the work of maintaining transmembrane ion gradients at rest; B60% of TEE), the thermic effect of feeding (the work of digestion; approximately 5-10% of TEE) and nonresting energy expenditure (NREE, energy expended in physical activity above resting; B30-40% of TEE). The effects of maintaining reduced weight on each of these compartments of energy expenditure are distinctly different. There is no significant decline in thermic effect of feeding following weight loss. 11 Some studies [16] [17] [18] report no change in REE following weight loss, whereas in others the maintenance of a reduced body weight is associated with modest reductions in REE, accounting for about 10-15% of the decline in TEE beyond that predicted on the basis of body composition changes. 11, 12, 19 The variability in study results probably reflects differences among studies in multiple factors, including degree and Adaptive thermogenesis in humans M Rosenbaum and RL Leibel duration of weight stability before and after weight loss, as well as changes in subject fitness and time spent in physical activity following weight loss. Regardless of whether changes in REE account for 10-15% of the changes in TEE following weight loss, NREE is clearly the compartment of energy expenditure that is most affected by changes in body weight, 11, 20 consistent with the importance of physical exercise in the successful maintenance of reduced weight.
9,21
The preeminence of NREEFaccounting for as much as 85-90% of the decline in TEE below predicted values in weight-reduced subjects 20, 22 could be due to declines in the actual amount of physical activity performed. In rodents, maintenance of a reduced body weight is associated with an increase, rather than a decrease, in the amount of time spent in physical activity, 23 probably reflecting food-seeking behavior. In-patient and outpatient studies of humans after weight loss have reported, respectively, no change or as much as a 30% increase in the amount of time that subjects spend moving each day, 11, 18 supporting the view that skeletal muscle work efficiency is increased 20 (as opposed to a decreased amount of motion per se) following weight loss. As these effects are most evident at low levels of work, that is, those commensurate with activities of daily living, it is reasonable to infer that some of the opposition to reduced weight maintenance can be diminished by exercising at higher levels of power output. 20, 24 Studies of skeletal muscle chemomechanical efficiency (energy expended above resting per unit of power generated) in weight-reduced subjects indicate that maintenance of a reduced body weight is associated with an approximate 20% increase in skeletal muscle work efficiency at low levels of exercise, whether measured by bicycle ergometry or 31 P nuclear magnetic resonance muscle spectroscopy. 20 Ergometric studies measure whole-body energy expenditure during stationary cycling. Energy efficiency is expressed as kcal consumed above REE per unit of power generated. Fuel utilization (fatty acid vs glucose oxidation) is assessed by the respiratory exchange ratio (ratio of CO 2 produced to O 2 consumed). In 31 P nuclear magnetic resonance spectroscopy, the ratio of inorganic phosphate (Pi), which increases during exercise because of the hydrolysis of ATP, to phosphocreatine (PCr), which decreases during exercise to replenish ATP, during exercise reflects the efficiency of muscle in generating a specific amount of power. In addition, the resting Pi reflects the relative fatty acid to glucose oxidative potential of muscle, and the phosphocreatine recovery constant (kPCr, a constant reflecting the exponential rate of PCr resynthesis following exercise, as well the maximal rate of oxygen consumption by muscle) reflects the muscle glycolytic potential. 20,25 31 P nuclear magnetic resonance spectroscopy can also be used to examine the in vivo ATP cost of single muscle contraction by measuring the PCr depletion rate following muscle stimulation in an ischemic limb (no PCr repletion until blood flow is restored).
26 Both these methods demonstrate that the maintenance of a 10% reduced body weight is associated with an approximate 20% increase in skeletal muscle chemomechanical efficiency and an approximate 18% relative increase in the fractional use of free fatty acids as fuel during low-level exercise 20, 27 (see Table 2 ). These results are consistent with studies of vastus lateralis muscle biopsies, in which the ratio of glycolytic (phosphofructokinase) to oxidative (cytochrome oxidase) enzyme activities is significantly decreased following weight loss. In statistical analyses, the changes in these enzyme ratios are sufficient to account for a significant fraction of the increased efficiency (R 2 ¼ 0.57, Po0.001) and free fatty acid oxidation (R 2 ¼ 0.31, Po0.01) that occurs during low-level exercise in weightreduced subjects. 27 
Neuroendocrine function
The neuroendocrine changes associated with the maintenance of a reduced body weight include increased activity of the hypothalamic-pituitary-adrenal (HPA) axis and decreased activity of the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-gonadal axes. The hypothalamic pro-opiomelanocortin (POMC)-melanocortin-melanocortin 4 receptor (MC4R) pathway, by virtue of its constituent neuronal outflow tracts to the autonomic nervous system (ANS), neuroendocrine axes and cortical tracts subserving food intake, may provide a central nexus for the sum of the integrated effects on energy expenditure and intake that are seen following weight loss.
1, 28, 29 The importance of the HPA axis in regulating body fat stores is illustrated by the effects of adrenalectomy on genetically obese rodents. The leptin-deficient or leptin-resistant mouse is hyperphagic, hypometabolic (similar to the weight-reduced human as discussed below), Abbreviations: COX, cytochrome oxidase; FFA, free fatty acid; kPCr phosphocreatine recovery constant; NME, net mechanical efficiency; NMR, nuclear magnetic resonance; PCr, phosphocreatine; PFK, phosphofructokinase; Pi, inorganic phosphate.
hypercortisolemic (unlike leptin-deficient and -resistant humans) and severely obese. These phenotypes are abolished by chemical or surgical adrenalectomy. 30 Hypercortisolemia results in loss of lean body mass and increases the partitioning of stored energy to fat.
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Studies of the HPA axis in which human subjects were assessed following variable weight loss regimens and lengths of time maintaining a reduced weight have found increases, 31 decreases 32 and no change 33 in indices of cortisol production after weight loss. Discrepancies among studies may reflect differences in subject populations regarding exercise, gender, age or weight loss regimens, as well as the degree of weight stability at the time of study. Thyroid hormone increases energy expenditure by increasing the heart rate, blood pressure and muscle ATP consumption (largely by stimulating the production of muscle ATPase). The thyroid hormone-deficient patient is hypotensive, bradycardic and lethargic and tends to gain weight, whereas the hyperthyroid patient is hypertensive and tachycardic and tends to lose weight. 34, 35 Both weight loss and the maintenance of a reduced body weight are associated with small but statistically significant decreases in circulating concentrations of triiodothyronine (T3) and increases in the circulating concentrations of its bioinactive enantiomer reverse T3 (rT3), suggesting that weight loss results in an increased peripheral conversion of thyroxine (T4) to rT3. 36 Thyroid-releasing hormone (TRH)-stimulated pituitary thyroid-stimulating hormone release is not diminished during energy restriction 37 or after weight loss 38 in
humans. The lack of increase in thyroid-stimulating hormone with weight loss, despite the decrease in circulating concentrations of T3, indicates that hypothalamic TRH release is decreased following weight loss. Energy restriction and maintenance of a reduced body weight are associated with decreased circulating leptin concentrations (see below). 39 Low ambient leptin, in turn, reduces POMC production in hypothalamic neurons. Decreased hypothalamic a-melanocyte-stimulating hormone, a proteolytic product of POMC, results in decreased activity of hypothalamic prothyroid-releasing hormone (pro-TRH) neurons in rats, 40 thus providing a possible mechanism for the decrease in hypothalamic-pituitary-thyroid axis activity following weight loss and the restoration of circulating concentrations of bioactive thyroid hormones following leptin replacement. 41 
ANS function
The ANS (both parasympathetic and sympathetic) includes major outflow tracts linking afferent biochemical signals regarding energy stores and efferent tracts regulating energy expenditure. Increased parasympathetic nervous system (PNS) activity slows heart rate and decreases REE. The sympathetic branch of the ANS modulates feeding behavior, directly increases heart rate and functions directly on the thyroid gland to increase the rate of secretion of the thyroid hormone. 42, 43 Sympathetic denervation of the arm in humans with palmar hyperhidrosis improves skeletal muscle work efficiency 44 in arm muscles, and chemical sympathectomy attenuates leptin-mediated increases in energy expenditure in rats. 45 Daily urinary norepinephrine excretion accounts for a significant proportion of the variance in energy expenditure and its subcomponents in weight-stable subjects. 36 The maintenance of a reduced body weight is associated with significant declines in sympathetic nervous system (SNS) tone (by analysis of heart rate following sequential parasympathetic and sympathetic blockade or 24-h urinary catecholamine excretion) and increases in PNS tone. 36, 43, 46 Changes in ANS tone associated with weight loss, in particular the decline in SNS tone, may account for a significant fraction of the hypometabolic state through direct effects on skeletal muscle, and/or indirectly through effects on circulating concentrations of thyroid hormones. 36, 47, 48 Thus, weight-loss-mediated changes in ANS activity may constitute a link between weight-loss-associated changes in energy and neuroendocrine homeostasis.
Brown adipose tissue
Brown adipose tissue (BAT) allows the uncoupling of mitochondrial substrate oxidation from ATP production, thereby releasing the energy of fatty acid oxidation as heat. 49 This is achieved through a 32-kd 'uncoupling protein' (UCP1) that is present in BAT but not in white adipose tissue. BAT has a rich sympathetic nerve and vascular supply and, in the presence of cold, weight gain and/or sympathetic nervous stimulation in rodents or exogenous or endogenous hypercatecholaminemia in humans, BAT activity increases, resulting in heat generation 50, 51 The activation of BAT is dependent on the integration of input from the SNS activation of adrenoreceptors (predominantly b 3 ), 52 with activation of at least one of the thyroid hormone receptor (TR) subtypes (TRa or TRb). 53 The leptin-sensitive declines in SNS activity and circulating concentrations of bioactive thyroid hormones following weight loss that are described above constitute a mechanism by which reduced obligatory and/or facultative thermogenesis by BAT could contribute to adaptive thermogenesis in humans. As little as 25 g of BAT going from a maximally active to a minimally active state following weight loss would be more than sufficient to account for the magnitude of decline in REE in weightreduced subjects that occurs beyond that predicted solely on the basis of weight and body composition changes. 54 Therefore, it is possible that a significant fraction of the unexplained variance in REE or in changes in REE following weight loss is attributable to changes in the activity of BAT. 55 However, although BAT is a major contributor to adaptive thermogenesis in small mammals, 56 its role in thermogenesis in adult humans remains unclear. In rodents, BAT contributes to both obligatory thermogenesis (the heat produced to maintain body temperature at rest) and
Adaptive thermogenesis in humans M Rosenbaum and RL Leibel facultative thermogenesis (the heat produced to maintain body temperature at ambient temperatures below thermoneutrality). 53 The cold intolerance of hypothyroid rodents reflects declines in both obligatory and facultative thermogenesis by BAT. 53 BAT is easily detected in rodents and clearly has a role in nonshivering thermogenesis in human neonates. Previous studies showed a lack of a significant presence of BAT in humans, except under extreme conditions of hypercatecholaminemia, 57 and, until recently, no studies have been carried out quantifying the contribution of BAT to total adaptive thermogenesis in humans. Recent advances in positron emission tomography (PET) scanning technology have allowed detailed imaging of BAT using uptake of 2-[ 18 F]fluoro-2-deoxy-glucose (FDG) and a hybrid scanner.
FDG uptake has been shown to correspond to the neck, supraclavicular, mediastinal, paraspinal, paravertebral and renal areas known to contain BAT in humans, [58] [59] [60] and FDG uptake in these areas (http://www.med.harvard.edu/JPNM/ chetan/normals/brown_fat/case.html) is inhibited by b-adrenergic blockade with propranolol. [61] [62] [63] In a recent series of papers, 54, 64, 65 several groups demonstrated the ability to detect BAT in healthy human beings with varying results as to whether thermal stimuli are necessary to detect it. In a retrospective study of [ 18 F]FDG (dose not specified) PET scans, Cypress et al. 54 detected BAT in 7.5% of women and in 3.1% of men studied under thermoneutral conditions. Lichtenbelt et al. 64 found that BAT was detected in 23 out of 24 subjects after cold exposure (16 1C for 2 h) but was not detected in three of these subjects who were also studied under thermoneutral conditions ([ 18 F]FDG dose of 74 MBq).
Finally, Virtanen et al. 65 reported that BAT was detected in 5 out of 5 adult subjects under both thermoneutral and postcold exposure (19 1C for 2 h) conditions using a higher dose (185 MBq) of [
18 F]FDG. The anatomical identification of BAT in humans using FDG does not necessarily reflect actual thermogenic activity of BAT, and the question remains as to whether BAT actually participates in resting thermogenesis, diet-induced thermogenesis or adaptive thermogenesis following weight loss or gain in humans. Increased glucose uptake by BAT is considered to reflect increased metabolic activity and thermogenesis. 56, 66, 67 This is the basis for the use of the FDG PET technique in localization of tumors and for the analysis of brain areas involved in different cognitive activities, as well as for examining myocardial metabolic activity. 56 Thus, the FDG uptake seen in BAT in adult man implies the existence of thermogenically active tissue in adult man. The magnitude of glucose uptake by BAT in FDG PET studies of subjects fasted and at rest, compared with other tissues, also suggests that BAT may have a significant role in glucose disposal in low-activity states (that is, the state in which we spend at least one-third of our lives). Assuming that reduced BAT activation following weight loss is a significant factor in adaptive thermogenesis, this effect is more likely to be evident in obligatory than facultative thermogenesis. In this environment, we spend almost all of our time in thermoneutral conditions, reducing the need for facultative thermogenesis and possibly contributing to the increasing prevalence of obesity. 68, 69 Further studies of the role of BAT in human thermogenesis outside the neonatal period are clearly indicated.
Metabolic responses to attempts to sustain weight gain
The metabolic changes that occur in subjects during maintenance of an elevated body weight following overfeeding involve many of the same systems, but are not, in fact, mirror images of the changes following weight loss. In a manner complementary to that seen following weight loss, the maintenance of an elevated body weight is associated with significant increases in circulating concentrations of T3 and T4, SNS tone, TEE, NREE and, of course, circulating leptin concentrations and a decrease in PNS tone and skeletal muscle work efficiency. However, there is no demonstrable effect of the maintenance of an elevated body weight on circulating concentrations of thyroid-stimulating hormone, and there is a much more marked effect of elevated weight maintenance on thermic effect of feeding and less of an effect on REE than is seen following weight loss. 11, 36, 70 Unlike the metabolic opposition to sustaining a reduced body weight, which persists long after weight reduction in mice 71 and humans, 72 the increased energy expenditure noted during short-term overfeeding in mice seems to be short lived. Rodents with diet-induced obesity demonstrate increased energy expenditure 73 and increased SNS tone 74 during the first 3-4 weeks of overfeeding. However, after a few months on a high-fat diet, these changes are no longer evident, 74, 75 indicating that resistance to sustained increased adiposity is less sustained than resistance to decreased adiposity. 69 The steadily increasing prevalence of obesity in humans also suggests that body fatness is facilitated more vigorously than body thinness. In addition to the lack of physiological persistence of strong metabolic opposition to weight gain, any 'defense' against further weight gain is stretched to the limit by this lifestyle, whereas opposition to sustaining weight loss remains potent and viable. 76 
Energy intake
As noted above, the long-term constancy of body weight suggests that energy intake and expenditure vary coordinately to maintain relatively stable energy stores. This 'coupling', which reduces energy intake in response to decreased energy expenditure, is disrupted during and after weight loss. 7 During dynamic weight loss, human beings and rodents are both hungrier (willing to eat more often) and less satiated (willing to eat more per meal). 77 Even during maintenance of a reduced weight, satiety remains
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Leptin in energy homeostasis
A critical mediator of these reciprocal changes in energy intake and expenditure is the hormone leptin. Leptin is an adipocyte-derived molecule that circulates in weight-stable individuals in direct proportion to fat mass. 79 The hyperphagic, hypometabolic phenotype of weight-reduced humans is similar to that of leptin-deficient or -unresponsive humans and rodents. 80 Circulating leptin concentrations are inversely correlated with hunger ratings in humans during weight loss, independent of the amount of weight or body fat lost. 81 Leptin administration reverses the hyperphagia associated with leptin deficiency in leptin-deficient mice and humans, 82, 83 and functions synergistically with sibutramine to reduce food intake in rodents. 84 Leptin suppresses food intake by promoting the production of anorexigenic neuropeptides (processed products of POMC) and reducing the expression of orexigens such as neuropeptide Y, agoutirelated peptide and melanin-concentrating hormone. Thus, decreased circulating leptin concentrations as a result of reduced fat mass have the net effect of stimulating food intake.
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The hypothalamic POMC-melanocortin-MC4R pathway is highly sensitive to circulating leptin concentrations and POMC expression is decreased in low-leptin states. 29, 85 Briefly, POMC is cleaved to a-melanocyte-stimulating hormone and beta-endorphin (b-EP), as well as to other bioactive molecules. As discussed previously, a-melanocytestimulating hormone stimulates release of hypothalamic pro-TRH. b-EP inhibits the release of hypothalamic corticotropin-releasing factor. Therefore, reduced ambient leptin induced by weight loss should be associated with decreased hypothalamic-pituitary-thyroid and increased HPA axis activity. Mice overexpressing the MC4R antagonists agouti signaling protein or agouti-related peptide 86 Fas well as rodents and humans with hypomorphic mutations in MC4R, 87 disruptions of POMC gene expression 88, 89 or of proneuropeptide (for example, POMC, pro-adrenocorticotropic hormone, pro-TRH) processing by prohormone convertases 90, 91 Fare obese. The importance of leptin in mediating these effects is reflected in the observation that fasting in rodents causes hypoleptinemia, which is associated with increased arcuate and brainstem neuropeptide Y and agouti-related peptide mRNA expression and decreased POMC mRNA in lean animals, but not in leptin-receptordeficient animals. 92 Administration of leptin to leptin-deficient rodents and humans in doses that restore circulating leptin concentrations to their physiological range increases energy expenditure, 93 decreases energy intake, increases SNS activity 94 and normalizes HPA, thyroid and gonadal function. 1, 29, 82 Yet, in humans (lean or obese) and rodents who are not leptin-deficient, induction of weight loss requires doses of leptin that produce plasma leptin concentrations over 10 times that of normal. 95, 96 Recent studies of the short-term administration of leptin to weight-reduced lean and obese subjects suggest that restoration of circulating concentrations of leptin to levels present before weight loss reverses the decreased energy expenditure and its associated declines in thyroid hormone and SNS activity and increase in skeletal muscle work efficiency, and increased energy intake, measured behaviorally and by functional magnetic resonance imaging of neuronal responses to food that characterize the weight-reduced state. 78, 82, 97 In this sense, the weight-reduced state may be perceived by CNS components relevant to energy homeostasis as a state of relative leptin deficiency. Pharmacotherapy activating the leptinsignaling pathway may help weight-reduced individuals to sustain their weight loss. 98 
Summary
Attempts to sustain weight loss invoke adaptive responses involving the coordinate actions of metabolic, neuroendocrine, autonomic and behavioral changes that 'oppose' the maintenance of a reduced bodyweight. This phenotype is distinct from that opposing dynamic weight loss per se. The multiple systems regulating energy stores and opposing the maintenance of a reduced body weight illustrate that body energy stores in general and fat stores in particular are actively 'defended' by interlocking bioenergetic and neurobiological physiologies. Important inferences can be drawn for therapeutic strategies by recognizing obesity as a state in which the human body actively opposes the 'cure' over long periods of time beyond the initial resolution of symptomatology.
